Cancer Causes & Control

, Volume 24, Issue 10, pp 1779–1787 | Cite as

The protective effect of coffee consumption on cutaneous melanoma risk and the role of GSTM1 and GSTT1 polymorphisms

  • Cristina Fortes
  • Simona Mastroeni
  • Paolo Boffetta
  • Gianluca Antonelli
  • Maria Antonietta Pilla
  • Giordano Bottà
  • Patrizia Anzidei
  • Federica Venanzetti
Original paper

Abstract

Purposes

The authors examined the association between coffee consumption and cutaneous melanoma and the implication of GSTM1 and GSTT1 polymorphisms.

Methods

A hospital-based case–control study was conducted in the inpatient wards of IDI-San Carlo Rome, Italy, including 304 incident cases of cutaneous melanoma and 305 controls. Information on socio-demographic characteristics, medical history, smoking, sun exposure, pigmentary characteristics and diet was collected for all subjects. Within the study, individual patterns at two polymorphic genes (GSTM1 and GSTT1) belonging to glutathione S-transferases family were investigated in 188 cases of cutaneous melanoma and 152 controls. Logistic regression was the method used to estimate odds ratio and 95 % confidence intervals.

Results

High frequency of coffee drinking (>once daily), compared with low-frequency consumption of coffee (≤7 times weekly) was associated with a protective effect for cutaneous melanoma (OR 0.46; 95 % CI 0.31–0.68) after adjusting for sex, age, education, hair colour, common nevi, skin phototype, and sunburn episodes in childhood. When stratified by GSTM1 and GSTT1 genotype, the protective effect of coffee was extremely high for subjects with both GSTM1 and GSTT1 null polymorphisms (OR 0.01; 95 % CI 0.0003–0.54).

Conclusions

Our results show a protective effect of coffee consumption for cutaneous melanoma, in particular for those with homozygous deletion for GSTM1 and GSTT1.

Keywords

Melanoma Coffee Diet GSTM1 GSTT1 Polymorphisms 

Notes

Acknowledgments

This work was supported by the Istituto Dermopatico dell’Immacolata, Istituto di Ricovero a Carattere Scientifico (Progetto Ricerca Corrente 2011, Italian Ministry of Health) and by the Consulenza Tecnica Accertamento Rischi e Prevenzione—Istituto Nazionale per l’Assicurazione contro gli Infortuni sul lavoro (INAIL).

Conflict of interest

The authors declare that they have no conflict of interests.

Supplementary material

10552_2013_255_MOESM1_ESM.docx (16 kb)
Supplementary material 1 (DOCX 17 kb)

References

  1. 1.
    De Vries E, Coebergh JW (2005) Melanoma incidence has risen in Europe. BMJ 331(7518):698PubMedCrossRefGoogle Scholar
  2. 2.
    Gandini S, Sera F, Cattaruzza MS et al (2005) Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 4:45–60CrossRefGoogle Scholar
  3. 3.
    Curtin JA, Fridlyand J, Kageshita T et al (2005) Distinct sets of genetic alterations in melanoma. N Engl J Med 353:2135–2147PubMedCrossRefGoogle Scholar
  4. 4.
    Fortes C, de Vries E (2008) Nonsolar occupational risk factors for cutaneous melanoma. Int J Dermatol 47:319–328PubMedCrossRefGoogle Scholar
  5. 5.
    International Agency for Research on Cancer (1991) IARC Mongraph on the evaluation of the carcinogenic risks to humans. In: Coffee, tea, mate, methylxanthines and methylglyoxal, vol 51. IARC, Lyon, FranceGoogle Scholar
  6. 6.
    Je Y, Giovannucci E (2012) Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 7:1700–1710CrossRefGoogle Scholar
  7. 7.
    Galeone C, Turati F, La Vecchia C et al (2010) Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control. Cancer Causes Control 2:1949–1959CrossRefGoogle Scholar
  8. 8.
    Turati F, Galeone C, Edefonti V et al (2012) A meta-analysis of coffee consumption and pancreatic cancer. Ann Oncol 2:311–318CrossRefGoogle Scholar
  9. 9.
    Braem MG, Onland-Moret NC, Schouten LJ et al (2012) Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr 95:1172–1181PubMedCrossRefGoogle Scholar
  10. 10.
    Veierød MB, Thelle DS, Laake P (1997) Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women. Int J Cancer 71:600–604PubMedCrossRefGoogle Scholar
  11. 11.
    Osterlind A, Tucker MA, Stone BJ et al (1988) The Danish case-control study of cutaneous malignant melanoma. IV. No association with nutritional factors, alcohol, smoking or hair dyes. Int J Cancer 42:825–828PubMedCrossRefGoogle Scholar
  12. 12.
    Green A, Bain C, McLennan R et al (1986) Risk factors for cutaneous melanoma in Queensland. Rec Results Cancer Res 102:76–97CrossRefGoogle Scholar
  13. 13.
    Naldi L, Gallus S, Tavani A et al (2004) Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Risk of melanoma and vitamin A coffee and alcohol: a case-control study from Italy. Eur J Cancer Prev 13:503–508PubMedCrossRefGoogle Scholar
  14. 14.
    Dong LM, Potter JD, White E et al (2008) Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299:2423–2436PubMedCrossRefGoogle Scholar
  15. 15.
    Parl FF (2005) Glutathione S-transferase genotypes and cancer risk. Cancer Lett 221:123–129PubMedCrossRefGoogle Scholar
  16. 16.
    Huber WW, Parzefall W (2005) Modification of N-acetyltransferases and glutathione S-transferases by coffee components: possible relevance for cancer risk. Methods Enzymol 401:307–341PubMedCrossRefGoogle Scholar
  17. 17.
    English DR, Mac Lennan R (1990) Epidemiological studies of melanocytic naevi protocol for identifying and recording naevi. IARC internal report no 90/002. International Agency for Research on Cancer, LyonGoogle Scholar
  18. 18.
    Freedberg IM et al (eds) (1999) Fitzpatrick’s dermatology in general medicine, 5th edn. McGraw-Hill, New YorkGoogle Scholar
  19. 19.
    Leffondré K, Abrahamowicz M, Siemiatycki J et al (2002) Modeling smoking history: a comparison of different approaches. Am J Epidemiol 156:813–823PubMedCrossRefGoogle Scholar
  20. 20.
    Fortes C, Forastiere F, Farchi S et al (2003) The protective effect of the Mediterranean diet on lung cancer. Nutr Cancer 46:30–37PubMedCrossRefGoogle Scholar
  21. 21.
    Gao Y, Zhang Q (1999) Polimorphisms of the GSTM1 and CYP2D6 genes associated with susceptibility to lung cancer in Chinese. Mutat Res 444:441–449PubMedCrossRefGoogle Scholar
  22. 22.
    Fortes C, Mastroeni S, Melchi F et al (2007) The association between residential pesticide use and cutaneous melanoma. Eur J Cancer 43:1066–1075PubMedCrossRefGoogle Scholar
  23. 23.
    Denkert C, Kobel M, Berger S et al (2001) Expression of cyclooxygenase 2 in human malignant melanoma. Cancer Res 61:303–308PubMedGoogle Scholar
  24. 24.
    Tabolacci C, Lentini A, Provenzano B et al (2010) Similar antineoplastic effects of nimesulide, a selective COX-2 inhibitor, and prostaglandin E1 on B16-F10 murine melanoma cells. Melanoma Res 20:273–279PubMedCrossRefGoogle Scholar
  25. 25.
    Kang NJ, Lee KW, Shin BJ et al (2009) Caffeic acid, a phenolic phytochemical in coffee, directly inhibits Fyn kinase activity and UVB-induced COX-2 expression. Carcinogenesis 30:321–330PubMedCrossRefGoogle Scholar
  26. 26.
    Lee WJ, Zhu BT (2006) Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 27:269–277PubMedCrossRefGoogle Scholar
  27. 27.
    Lee KJ, Jeong HG (2007) Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. Toxicol Lett 173:80–87PubMedCrossRefGoogle Scholar
  28. 28.
    Yamada Y, Yasui H, Sakurai H (2006) Suppressive effect of caffeic acid and its derivatives on the generation of UVA-induced reactive oxygen species in the skin of hairless mice and pharmacokinetic analysis on organ distribution of caffeic acid in ddY mice. Photochem Photobiol 82:1668–1676PubMedGoogle Scholar
  29. 29.
    Armstrong BK, White E, Saracci R (1992) Principles of exposure measurement in epidemiology. Oxford University Press, New YorkGoogle Scholar
  30. 30.
    Lampe JW (2009) Interindividual differences in response to plant-based diets: implications for cancer risk. Am J Clin Nutr 89:1553S–1557SPubMedCrossRefGoogle Scholar
  31. 31.
    Mössner R, Anders N, König IR et al (2007) Variations of the melanocortin-1 receptor and the glutathione-S transferase T1 and M1 genes in cutaneous malignant melanoma. Arch Dermatol Res 298:371–379PubMedCrossRefGoogle Scholar
  32. 32.
    Chan EC, Lam SY, Fu KH et al (2005) Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet 162:10–20PubMedCrossRefGoogle Scholar
  33. 33.
    Ibarrola-Villava M, Martin-Gonzalez M, Lazaro P et al (2012) Role of glutathione S-transferases in melanoma susceptibility: association with GSTP1 rs1695 polymorphism. Br J Dermatol 166:1176–1183PubMedCrossRefGoogle Scholar
  34. 34.
    Heagerty A, Smith A, English J et al (1994) Glutathione S-transferase GSTM1 phenotypes and protection against cutaneous tumours. Lancet 343:266–268PubMedCrossRefGoogle Scholar
  35. 35.
    Kanetsky PA, Holmes R, Walker A et al (2001) Interaction of glutathione S-transferase M1 and T1 genotypes and malignant melanoma. Cancer Epidemiol Biomark Prev 10:509–513Google Scholar
  36. 36.
    Fortes C, Mastroeni S, Boffetta P et al (2011) Polymorphisms of GSTM1 and GSTT1, sun exposure and the risk of melanoma: a case–control study. Acta Derm Venereol 91:284–289PubMedCrossRefGoogle Scholar
  37. 37.
    Palli D, Masala G, Peluso M et al (2004) The effects of diet on DNA bulky adduct levels are strongly modified by GSTM1 genotype: a study on 634 subjects. Carcinogenesis 25:577–584PubMedCrossRefGoogle Scholar
  38. 38.
    Lampe JW, Chen C, Li S et al (2000) Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 9:787–793PubMedGoogle Scholar
  39. 39.
    Epplein M, Wilkens LR, Tiirikainen M et al (2009) Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev 18:314–320PubMedCrossRefGoogle Scholar
  40. 40.
    Gervasini G, San Jose C, Carrillo JA et al (2010) GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high-incidence area. Nutr Cancer 62:750–758PubMedCrossRefGoogle Scholar
  41. 41.
    Borst L, Buchard A, Rosthøj S et al (2012) Gene dose effects of GSTM1, GSTT1 and GSTP1 polymorphisms on outcome in childhood acute lymphoblastic leukemia. J Pediatr Hematol Oncol 34:38–42PubMedCrossRefGoogle Scholar
  42. 42.
    Coles BF, Kadlubar FF (2003) Detoxification of electrophilic compounds by glutathione S-transferase catalysis:determinants of individual response to chemical carcinogens and chemotherapeutic drugs. BioFactors 17:115–130PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 2013

Authors and Affiliations

  • Cristina Fortes
    • 1
  • Simona Mastroeni
    • 1
  • Paolo Boffetta
    • 2
    • 3
  • Gianluca Antonelli
    • 1
  • Maria Antonietta Pilla
    • 1
  • Giordano Bottà
    • 4
  • Patrizia Anzidei
    • 5
  • Federica Venanzetti
    • 5
  1. 1.Clinical Epidemiology UnitIstituto Dermopatico dell’Immacolata, IDI-IRCSSRomeItaly
  2. 2.Mount Sinai School of MedicineInstitute for Translational Epidemiology and Tisch Cancer InstituteNew YorkUSA
  3. 3.International Prevention Research InstituteLyonFrance
  4. 4.Parasitology Unit, Department of Public Health and Infectious DiseasesUniversity of Rome “La Sapienza”RomeItaly
  5. 5.Technical Directorate for Risk Assessment and PreventionItalian Workers’ Compensation Authority (INAIL)RomeItaly

Personalised recommendations